Lvp solution systemic is used for dehydration, peritoneal dialysis Reviews & ratings Add a review View more Dapagliflozin Dapagliflozin (Farxiga) is an SGLT2 inhibitor that is mainly used alongside diet and exercise to ... Reviews & ratings 4.8 / 10 193 Reviews View more Jardiance Jardi...
The most exciting positive effects have recently been obtained with SGLT 2 inhibitors—a new class of antidiabetic drug which inhibits the sodium–glucose cotransporter and increases glucose excretion by the kidneys—and glucagon-like peptide 1 (GLP-1) receptor agonists. Finally, the importance of...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus responsible for the current coronavirus disease 2019 (COVID-19) pandemic, has infected over 3.5 million people all over the world since the first case was reported from Wuhan, China 5 months ago. As more epidemiologica...
Despite the recent expansion of antidiabetic agents such as GLP-1 receptor agonists and SGLT-2is, glycemic control remains suboptimal in many patients. Approximately half of all type 2 diabetic patients in the United States and worldwide fail to achieve the glycemic target of A1c ≥ 7.0% ...
Sodium-glucose cotransporter 2 (SGLT2) inhibitors to treattype 2 diabetesappear to confer greater cardiovascular benefit than glucagon-like peptide-1 (GLP-1) receptor agonists among older adults with a history of cardiovascular disease (CVD), according to a new study. ...
The EMPA-REG OUTCOME trial is part of the new wave of cardiovascular (CV) outcome trials required by the US Food and Drug Administration (FDA) for all new diabetes drugs.Empagliflozinis in the relatively new class of antihyperglycemics known as sodium-glucose cotransporter 2 (SGLT2) inhibitors...
(SGLT2), which causes a reduction in the reabsorption of filtered glucose. The drug also causes the patient to excrete excess glucose through their urine, lowering plasma glucose concentrations overall. This medication has been shown to lower A1C levels by 0.7% to 1% but is particularly favored...
SGLT2 inhibitors. Canagliflozin can increase the risk of digital lower-limb amputation in patients with type 2 diabetes, and reporting side-effects is urged. Diabetes specialist care in acute care units is fundamental (Medicines and Healthcare products Regulato...
Post-chemotherapy dilated cardiomyopathy is mainly rep- resented in women for the frequent use of anthracyclines in the treatment of breast cancer, a known cardio-toxic drug. It has been shown that doxorubicin decreases LVEF by about 10–15% at a standard dose of 240 mg/sqm and has a ...
GM-CSF is an adjuvant, a substance that activates the immune response to the vaccine. Use of an adjuvant is one strategy utilized by researchers to stimulate an immune response against tumor cells, which are generally not recognized by the immune system as foreign. Cell Genesys is now studying...